Ray Dalio’s Aehr Test Systems AEHR Stock Holding History

Ray Dalio’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,873	Closed	-$292K	–	1003
2026 Q1	$292K	Buy	+7,873	New	+$252K	﹤0.01%	950
2025 Q4	–	Sell	-8,394	Closed	-$253K	–	1042
2025 Q3	$253K	Buy	+8,394	New	+$182K	﹤0.01%	983

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ray Dalio's AEHR Position: Q2 2026 in Review

Ray Dalio sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 7,873 shares — an estimated $292K sold.

Ray Dalio first reported a position in AEHR in Q3 2025 and held it in 2 quarters. The position peaked at $292K in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Ray Dalio reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
Ray Dalio sold 7,873 Aehr Test Systems shares in Q2 2026, an estimated $292K.
Ray Dalio first reported a position in Aehr Test Systems in Q3 2025 and held it in 2 quarters.
Ray Dalio's Aehr Test Systems position peaked at $292K in Q1 2026.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.